Polymer-based prolonged-release nanoformulation of duloxetine: fabrication, characterization and neuropharmacological assessments

References

• Organization WH. Depression. Fact sheet No. 369. 2017.
   Google Scholar
• Luppino FS , de Wit LM , Bouvy PF , et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–229.
   PubMed Web of Science ®Google Scholar
• Miller S , Dell'Osso B , Ketter TA. The prevalence and burden of bipolar depression. J Affect Disord. 2014;169(1):S3–S11.
   PubMedGoogle Scholar
• Summergrad P. Investing in global mental health: the time for action is now. Lancet Psychiatr. 2016;3(5):390–391.
   PubMed Web of Science ®Google Scholar
• Lu Y , Tang C , Liow CS , et al. A regressional analysis of maladaptive rumination, illness perception and negative emotional outcomes in Asian patients suffering from depressive disorder. Asian J Psychiatr. 2014;12:69–76.
   PubMedGoogle Scholar
• Organization WH. World health statistics 2016: monitoring health for the SDGs sustainable development goals. Geneva, Switzerland: World Health Organization; 2016.
   Google Scholar
• Organization WH. Preventing suicide: a global imperative: World Health Organization. 2014.
   Google Scholar
• Excellence NIfHaC. Depression in adults: recognition and management. 2016. Available from: https://www.nice.org.uk/guidance/cg90.
   Google Scholar
• Cleare A , Pariante CM , Young AH , et al. ; Members of the Consensus Meeting . Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459–525.
   PubMed Web of Science ®Google Scholar
• Holtzheimer PE , Nemeroff CB. Novel targets for antidepressant therapies. Curr Psychiatry Rep. 2008;10(6):465–473.
   PubMedGoogle Scholar
• Zhou J. Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future. 2004;29(12):1235–1244.
   PubMed Web of Science ®Google Scholar
• Kirwin JL , Gören JL. Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. Pharmacotherapy. 2005;25(3):396–410.
   PubMed Web of Science ®Google Scholar
• Zhao R-k , Cheng G , Tang J , et al. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single-and multiple-dose study. Clin Ther. 2009;31(5):1022–1036.
   PubMed Web of Science ®Google Scholar
• D’Souza S , Faraj JA , Giovagnoli S , et al. Development of risperidone PLGA microspheres. J Drug Delivery. 2014;2014:1–11.
   Google Scholar
• Erdemli Ö , Keskin D , Tezcaner A , et al. Influence of excipients on characteristics and release profiles of poly(ε-caprolactone) microspheres containing immunoglobulin G. Mater Sci Eng C Mater Biol Appl. 2015;48:391–399.
   PubMed Web of Science ®Google Scholar
• Zhai P , Chen XB , Schreyer DJ , et al. PLGA/alginate composite microspheres for hydrophilic protein delivery. Mater Sci Eng C Mater Biol Appl. 2015;56:251–259.
   PubMed Web of Science ®Google Scholar
• Sinha VR , Bansal K , Kaushik R , et al. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004;278(1):1–23.
   PubMed Web of Science ®Google Scholar
• Mao S , Xu J , Cai C , et al. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm. 2007;334(1-2):137–148.
   PubMed Web of Science ®Google Scholar
• Mitragotri S , Burke PA , Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014;13(9):655–672.
   PubMed Web of Science ®Google Scholar
• Chaurasia S , Kumar N , Patel RR , et al. Optimization of parameters for the fabrication of curcumin loaded polymeric nanoparticles using Taguchi robust design. Adv Sci Lett. 2014;20(5):1028–1038.
   Google Scholar
• Ran X , Shi L , Zhang K , et al. The gelation ability and morphology study of organogel system based on calamitic hydrazide derivatives. J Nanomater. 2015;2015:1–6.
   Web of Science ®Google Scholar
• Li Y , Pei Y , Zhang X , et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 2001;71(2):203–211.
   PubMed Web of Science ®Google Scholar
• Willner P , Towell A , Sampson D , et al. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl)). 1987;93(3):358–364.
   PubMed Web of Science ®Google Scholar
• Porsolt RD , Bertin A , Jalfre M. Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol. 1978;51(3):291–294.
   PubMed Web of Science ®Google Scholar
• Clayton KN , Salameh JW , Wereley ST , et al. Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. Biomicrofluidics. 2016;10(5):054107–054107.
   PubMed Web of Science ®Google Scholar
• Tekade RK. Basic fundamentals of drug delivery. London: Elsevier Science; 2018.
   Google Scholar
• Seju U , Kumar A , Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater. 2011;7(12):4169–4176.
   PubMed Web of Science ®Google Scholar
• Shah N , Chaudhari K , Dantuluri P , et al. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target. 2009;17(7):533–542.
   PubMed Web of Science ®Google Scholar
• Nahata T , Saini TR. D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole. Drug Dev Ind Pharm. 2008;34(7):668–675.
   PubMed Web of Science ®Google Scholar
• Solano AGR , de Fátima Pereira A , de Faria LGA , et al. Etoposide-loaded poly(lactic-co-glycolic acid) intravitreal implants: in vitro and in vivo evaluation. AAPS PharmSciTech. 2018;19(4):1652–1661.
   PubMed Web of Science ®Google Scholar
• McDonald PF , Lyons JG , Geever LM , et al. In vitro degradation and drug release from polymer blends based on poly(dl-lactide), poly(l-lactide-glycolide) and poly+µ-caprolactone. J Mater Sci. 2010;45(5):1284–1292.
   Web of Science ®Google Scholar
• Nanjwade B , et al. A novel pH-triggered in situ gel for sustained ophthalmic delivery of ketorolac tromethamine. Asian J Pharm Sci. 2009;4:189–199.
   Google Scholar
• Calvo P , Vila-Jato JL , Alonso MJ. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J Pharm Sci. 1996;85(5):530–536.
   PubMed Web of Science ®Google Scholar
• Chaurasia S , Mounika K , Bakshi V , et al. 3-month parenteral PLGA microsphere formulations of risperidone: Fabrication, characterization and neuropharmacological assessments. Mater Sci Eng C Mater Biol Appl. 2017;75:1496–1505.
   PubMed Web of Science ®Google Scholar
• Fu X , Ping Q , Gao Y. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J Microencapsul. 2005;22(7):705–714.
   PubMed Web of Science ®Google Scholar
• Yin M-m , Zheng Y , Chen F-l. Pyraclostrobin-loaded poly (lactic-co-glycolic acid) nanospheres: Preparation and characteristics. J Integ Agricult. 2018;17(8):1822–1832.
   Web of Science ®Google Scholar
• Sánchez-López E , Egea MA , Cano A , et al. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization. Colloids Surf B Biointerfaces. 2016;145:241–250.
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110–111.
   PubMedGoogle Scholar
• Costa P , Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–133.
   PubMed Web of Science ®Google Scholar
• Fazil M , Md S , Haque S , et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47(1):6–15.
   PubMed Web of Science ®Google Scholar
• Fernandez JW , Grizzell JA , Philpot RM , et al. Postpartum depression in rats: differences in swim test immobility, sucrose preference and nurturing behaviors. Behav Brain Res. 2014;272:75–82.
   PubMed Web of Science ®Google Scholar
• Ruan C-S , Wang S-F , Shen Y-J , et al. Deletion of TRIM32 protects mice from anxiety- and depression-like behaviors under mild stress. Eur J Neurosci. 2014;40(4):2680–2690.
   PubMed Web of Science ®Google Scholar
• Alam MI , Baboota S , Ahuja A , et al. Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. J Psychiatr Res. 2012;46(9):1133–1138.
   PubMed Web of Science ®Google Scholar